A Study to Assess the Incidence of Deep Vein Thrombosis (DVT) Following Prophylactic Intravenous Administration of Recombinant Human Antithrombin(rhAT) to Hereditary Antithrombin (AT) Deficient Patients in High Risk Situations.
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Antithrombin alfa (Primary)
- Indications Deep vein thrombosis
- Focus Registrational; Therapeutic Use
- Sponsors rEVO Biologics
Most Recent Events
- 05 Nov 2010 New trial record.